Lorlatinib produced by Lucius Pharmaceuticals is available in two specifications, the price of 100mg lorlatinib is about $345, and the price of 25mg lorlatinib is about $111. The specific price may vary depending on the version channel and other factors. Further consultation or verification of relevant information is recommended before purchase.
Patients with non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) rearrangement or ROS proto-oncogene 1 (ROS1) rearrangement are generally sensitive to tyrosin···【more】
Article source:Lucius LaosRelease date:2024-11-20Recommended:138
Lorlatinib is a highly potent third-generation ALK and ROS1 tyrosine kinase inhibitor with good brain penetration and broad coverage of ALK mutations. In a phase 1 study, it showed···【more】
Article source:Lucius LaosRelease date:2024-11-20Recommended:163
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: